2021
DOI: 10.3390/antiox10081220
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione Participation in the Prevention of Cardiovascular Diseases

Abstract: Cardiovascular diseases (CVD) (such as occlusion of the coronary arteries, hypertensive heart diseases and strokes) are diseases that generate thousands of patients with a high mortality rate worldwide. Many of these cardiovascular pathologies, during their development, generate a state of oxidative stress that leads to a deterioration in the patient’s conditions associated with the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Within these reactive species we find superoxide… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
66
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 81 publications
(68 citation statements)
references
References 186 publications
(286 reference statements)
1
66
0
1
Order By: Relevance
“… 22 In addition, GSH deficiency leads to the progression of diabetes and the development of complications. 23 , 24 …”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“… 22 In addition, GSH deficiency leads to the progression of diabetes and the development of complications. 23 , 24 …”
Section: Introductionmentioning
confidence: 99%
“…22 In addition, GSH deficiency leads to the progression of diabetes and the development of complications. 23,24 Vitamin D is critical for maintaining homeostasis in T2DM patients. However, the effects of vitamin D in the treatment of T2DM in Southern Chinese people remain to be further investigated.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, dipeptides showed antioxidant activity by keeping a steady level of GSH t . The glutathione antioxidant system has been shown to play an important role in the maintenance of good health and in disease prevention [41]. GSH cannot be administered directly because two pharmaceutical problems have been observed: poor bioavailability with oral administration, and a short half-life (2 min) with intravenous administration [42].…”
Section: Discussionmentioning
confidence: 99%
“…The mitochondria-targeted antioxidants are especially suitable when ROS are generated by the mitochondrial ETC and were found to improve VILI in mouse preclinical settings [ 181 ]. However, the most important endogenous compound in terms of antioxidant capacity is GSH [ 182 ]. This is also true in lung inflammation [ 183 ].…”
Section: Methodsmentioning
confidence: 99%